The endocannabinoid system drives neural progenitor proliferation

The discovery of multipotent neural progenitor (NP) cells has provided strong support for the existence of neurogenesis in the adult brain. However, the signals controlling NP proliferation remain elusive. Endocannabinoids, the endogenous counterparts of marijuana‐derived cannabinoids, act as neuromodulators via presynaptic CB1 receptors and also control neural cell death and survival. Here we show that progenitor cells express a functional endocannabinoid system that actively regulates cell proliferation both in vitro and in vivo. Specifically, NPs produce endocannabinoids and express the CB1 receptor and the endocannabinoid‐inactivating enzyme fatty acid amide hydrolase (FAAH). CB1 receptor activation promotes cell proliferation and neurosphere generation, an action that is abrogated in CB1‐deficient NPs. Accordingly, proliferation of hippocampal NPs is increased in FAAH‐deficient mice. Our results demonstrate that endocannabinoids constitute a new group of signaling cues that regulate NP proliferation and thus open novel therapeutic avenues for manipulation of NP cell fate in the adult brain.

[1]  R. Hampson,et al.  Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.

[2]  D. J. Rademacher,et al.  Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia , 2004, Neuroscience.

[3]  Gerd Kempermann,et al.  Milestones of neuronal development in the adult hippocampus , 2004, Trends in Neurosciences.

[4]  K. Jin,et al.  Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. , 2004, Molecular pharmacology.

[5]  P. Jonas,et al.  Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus , 2004, Nature.

[6]  R. Vink,et al.  The “Dark Side” of Endocannabinoids: A Neurotoxic Role for Anandamide , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  A. Ullrich,et al.  Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor α-Converting Enzyme (TACE/ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor , 2004, Cancer Research.

[8]  A. Álvarez-Buylla,et al.  For the Long Run Maintaining Germinal Niches in the Adult Brain , 2004, Neuron.

[9]  D. Steindler,et al.  Neural stem and progenitor cells in nestin‐GFP transgenic mice , 2004, The Journal of comparative neurology.

[10]  Hongjun Song,et al.  Neurogenesis in the adult brain: new strategies for central nervous system diseases. , 2004, Annual review of pharmacology and toxicology.

[11]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[12]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[13]  M. Guzmán,et al.  Cannabinoids: potential anticancer agents , 2003, Nature Reviews Cancer.

[14]  M. Maccarrone,et al.  The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis , 2003, Cell Death and Differentiation.

[15]  F. Walsh,et al.  The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response , 2003, The Journal of cell biology.

[16]  I. Galve-Roperh,et al.  The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway* , 2002, The Journal of Biological Chemistry.

[17]  J. Borrell,et al.  Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling , 2002, The Journal of Neuroscience.

[18]  K. Jin,et al.  Increased Severity of Stroke in CB1 Cannabinoid Receptor Knock-Out Mice , 2002, The Journal of Neuroscience.

[19]  M. L. de Ceballos,et al.  Cannabinoids Protect Astrocytes from Ceramide-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway* , 2002, The Journal of Biological Chemistry.

[20]  M. Nakafuku,et al.  Regeneration of Hippocampal Pyramidal Neurons after Ischemic Brain Injury by Recruitment of Endogenous Neural Progenitors , 2002, Cell.

[21]  W. Zieglgänsberger,et al.  The endogenous cannabinoid system controls extinction of aversive memories , 2002, Nature.

[22]  T. Möller,et al.  Astrocytes in Culture Produce Anandamide and Other Acylethanolamides* , 2002, The Journal of Biological Chemistry.

[23]  R. Mechoulam,et al.  Endocannabinoids and Neuroprotection , 2002, Science's STKE.

[24]  F. Gage,et al.  Functional neurogenesis in the adult hippocampus , 2002, Nature.

[25]  K. Nicolay,et al.  Exogenous Anandamide Protects Rat Brain against Acute Neuronal Injury In Vivo , 2001, The Journal of Neuroscience.

[26]  Sally Temple,et al.  The development of neural stem cells , 2001, Nature.

[27]  B. Cravatt,et al.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Cortés,et al.  Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation , 2000, Nature Medicine.

[29]  F. Berrendero,et al.  The endogenous cannabinoid system and brain development , 2000, Trends in Neurosciences.

[30]  D. Piomelli,et al.  A second endogenous cannabinoid that modulates long-term potentiation , 1997, Nature.

[31]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[32]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[33]  S. Gaetani,et al.  Modulation of anxiety through blockade of anandamide hydrolysis , 2003, Nature Medicine.